[1]
A. Zavrelova, J. Radocha, P. Paterova, P. Zak, B. Visek, and M. Sima, “BETTER OUTCOME OF HIGH-DOSE CEFTAZIDIME IN HEMATO – ONCOLOGICAL PATIENTS WITH INFECTIONS CAUSED BY EXTENSIVELY DRUG-RESISTANT PSEUDOMONAS AERUGINOSA”, Mediterr J Hematol Infect Dis, vol. 15, no. 1, p. e2023001, Dec. 2022.